Clinical Relevance of Plasma miR-21 in New-Onset Systemic Lupus Erythematosus Patients

Journal of Clinical Laboratory Analysis

Volumn 28, Issue 6, 2014, Pages 446-451

  Tang, Zhao Ming ^a   Fang, Min ^a   Wang, Jin Ping ^a   Cai, Peng Cheng ^a   Wang, Ping ^a   Hu, Li Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

biomarker; miR 21; plasma; real time polymerase chain reaction; systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; CYSTATIN C; MICRORNA 21; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHINA; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; LEUKOCYTE COUNT; MALE; PROTEIN BLOOD LEVEL; PYURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; URIC ACID BLOOD LEVEL;

EID: 85006427832     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21708     Document Type: Article

References (30)

1. Li R, Sun J, Ren LM, et al. 2012. Epidemiology of eight common rheumatic diseases in China: A large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) 51(4):721–729.
2. Mok CC. 2011. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 20(7):767–771.
3. Shen N, Liang D, Tang Y, de Vries N, Tak PP. 2012. MicroRNAs—Novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol 8(12):701–709.
4. Wang G, Tam L, Li EK, et al. 2011. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20(5):493–500.
5. Wang G, Tam LS, Li EK, et al. 2010. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol 37(12):2516–2522.
6. Wang H, Peng W, Ouyang X, Li W, Dai Y. 2012. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 160(3):198–206.
7. Lawrie CH, Gal S, Dunlop HM, et al. 2008. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141(5):672–675.
8. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. 2011. Serum MicroRNAs as biomarkers for hepatocellular carcinoma in chinese patients with chronic hepatitis B virus infection. PLoS One 6(12):e28486.
9. Zhou J, Yu L, Gao X, et al. 2011. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29(36):4781–4788.
10. Mitchell PS, Parkin RK, Kroh EM, et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513–10518.
11. Zile MR, Mehurg SM, Arroyo JE, Stroud RE, DeSantis SM, Spinale FG. 2011. Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ Cardiovas Genet 4(6):614–619.
12. Tsujiura M, Ichikawa D, Komatsu S, et al. 2010. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102(7):1174–1179.
13. Komatsu S, Ichikawa D, Tsujiura M, et al. 2013. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res 33(1):271–276.
14. Stagakis E, Bertsias G, Verginis P, et al. 2011. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 70(8):1496–1506.
15. Pan W, Zhu S, Yuan M, et al. 2010. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184(12):6773–6781.
16. Carlsen AL, Schetter AJ, Nielsen CT, et al. 2013. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 65(5):1324–1334.
17. Kroh EM, Parkin RK, Mitchell PS, Tewari M. 2010. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50(4):298–301.
18. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. 2010. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127(1):118–126.
19. Tomasetti M, Staffolani S, Nocchi L, et al. 2012. Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. Clin Biochem 45(7–8):575–581.
20. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408.
21. Tomimaru Y, Eguchi H, Nagano H, et al. 2012. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 56(1):167–175.
22. Olivieri F, Spazzafumo L, Santini G, et al. 2012. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev 133(11–12):675–685.
23. Huang RS, Gamazon ER, Ziliak D, et al. 2011. Population differences in microRNA expression and biological implications. RNA biology 8(4):692–701.
24. Koshiol J, Wang E, Zhao Y, Marincola F, Landi MT. 2010. Strengths and limitations of laboratory procedures for microRNA detection. Cancer Epidemiol Biomarkers Prev 19(4):907–911.
25. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. 2011. Analysis of circulating microRNA: Preanalytical and analytical challenges. Clin Chem 57(6):833–840.
26. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11(2):141–147.
27. Beebe AM, Cua DJ, de Waal Malefyt R. 2002. The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4–5):403–412.
28. Te JL, Dozmorov IM, Guthridge JM, et al. 2010. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 5(5):e10344.
29. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. 2009. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29(7):749–754.
30. Jones CI, Zabolotskaya MV, King AJ, et al. 2012. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. Br J Cancer 107(12):1987–1996.